Adherence to oral anticoagulants in patients with non-valvular atrial fibrillation: the role of patients’ characteristics and out-of-pocket payments

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American heart association. Circulation. 2019;139(10):56–528. doi: 10.1161/CIR.0000000000000659
   PubMed Web of Science ®Google Scholar
• Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837–847. doi: 10.1161/CIRCULATIONAHA.113.005119
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. doi: 10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Zoni-Berisso M, Lercari F, Carazza T, et al. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014;6:213–220. doi: 10.2147/CLEP.S47385
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):1–88. doi: 10.1093/ejcts/ezw313
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–988. doi: 10.1161/01.str.22.8.983
   PubMed Web of Science ®Google Scholar
• Lin HJ, Wolf PA, Kelly-Hayes M, et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke. 1996;27(10):1760–1764. doi: 10.1161/01.str.27.10.1760
   PubMed Web of Science ®Google Scholar
• Gladstone DJ, Spring M, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370(26):2467–2477. doi: 10.1056/NEJMoa1311376
   PubMed Web of Science ®Google Scholar
• Andrade J, Khairy P, Dobrev D, et al. The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. Circ Res. 2014;114(9):1453–1468. doi: 10.1161/CIRCRESAHA.114.303211
   PubMed Web of Science ®Google Scholar
• Deshpande CG, Kogut S, Laforge R, et al. Impact of medication adherence on risk of ischemic stroke, major bleeding and deep vein thrombosis in atrial fibrillation patients using novel oral anticoagulants. Curr Med Res Opin. 2018;34(7):1285–1292. doi: 10.1080/03007995.2018.1428543
   PubMed Web of Science ®Google Scholar
• Mega JL. A new era for anticoagulation in atrial fibrillation. N Engl J Med. 2011;365(11):1052–1054. doi: 10.1056/NEJMe1109748
   PubMed Web of Science ®Google Scholar
• Zhu J, Alexander GC, Nazarian S, et al. Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010–2017. Pharmacotherapy. 2018;38(9):907–920. doi: 10.1002/phar.2158
   PubMed Web of Science ®Google Scholar
• Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian cardiovascular society/Canadian heart rhythm society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36(12):1847–1848. doi: 10.1016/j.cjca.2020.09.001
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021;42:507. doi: 10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Montinari MR, Minelli S, De Caterina R. Eighty years of oral anticoagulation: learning from history. Vascul Pharmacol. 2021;141:106918.
   PubMed Web of Science ®Google Scholar
• Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145:242–255. doi: 10.1161/CIRCULATIONAHA.121.056355
   PubMed Web of Science ®Google Scholar
• Zirlik A, Bode C. Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation. J Thromb Thrombolysis. 2017;43(3):365–379. doi: 10.1007/s11239-016-1446-0
   PubMed Web of Science ®Google Scholar
• Douketis JD, Lip GY. Perioperative management of patients receiving anticoagulants. UpToDate. 2022. [cited 2023 Jan 27]. Available from: https://www.uptodate.com/contents/perioperative-management-of-patients-receiving-anticoagulants#H753184
   Google Scholar
• Medicines Patent Pool. Exploring the expansion of the medicines patent pool’s mandate to patented essential medicines. 2018 [cited 2022 Dec 21]. Available from: https://medicinespatentpool.org/uploads/2018/05/DEC2019_Feasibility-Study-Expansion-of-the-MPP-Mandate-Appendix.pdf
   Google Scholar
• Choi JC, Dibonaventura MD, Kopenhafer L, et al. Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation. Patient Prefer Adherence. 2014;8:167–177. doi: 10.2147/PPA.S56187
   PubMed Web of Science ®Google Scholar
• Kirley K, GouthamRao BV, Bauer V, et al. The role of NOACs in atrial fibrillation management: a qualitative study. J Atr Fibrillation. 2016;9(1):1416. doi: 10.4022/jafib.1416
   PubMedGoogle Scholar
• Monagle SR, Hirsh J, Bhagirath VC, et al. Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. J Thromb Thrombolysis. 2018;46(3):310–315. doi: 10.1007/s11239-018-1692-4
   PubMed Web of Science ®Google Scholar
• Teppo K, Jaakkola J, Biancari F, et al. Association of income and educational levels with adherence to direct oral anticoagulant therapy in patients with incident atrial fibrillation: a Finnish nationwide cohort study. Pharmacol Res Perspect. 2022;10(3):961. doi: 10.1002/prp2.961
   Web of Science ®Google Scholar
• Al-Jumaili AA. Iraq pharmaceutical country profile 2020. 2020 [cited 2023 Dec 23]. Available from: https://www.researchgate.net/profile/Ali-Azeez-Al-Jumaili/publication/350043204_IRAQ_PHARMACETUICAL_COUNTRY_PROFILE_2020/links/620c9b72cf7c2349ca17ece0/IRAQ-PHARMACETUICAL-COUNTRY-PROFILE-2020.pdf?origin=publication_detail
   Google Scholar
• World Bank. Addressing the human capital crisis: a public expenditure review for human development sectors in Iraq. 2021 [cited 2022 Dec 17]. Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/35648/Iraq-HD-PER-Final.pdf?sequence=5&isAllowed=y
   Google Scholar
• Freedman B, Hindricks G, Banerjee A, et al. World heart federation roadmap on atrial fibrillation – a 2020 update. Glob Heart. 2021;16(1):41. doi: 10.5334/gh.1023
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Foy CG, Kazis LE, et al. Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med. 2017;377(8):733–744. doi: 10.1056/NEJMoa1611179
   PubMed Web of Science ®Google Scholar
• Bress AP, Bellows BK, King JB, et al. Cost-effectiveness of intensive versus standard blood-pressure control. N Engl J Med. 2017;377(8):745–755. doi: 10.1056/NEJMsa1616035
   PubMed Web of Science ®Google Scholar
• Chan HK, Hassali MA. Modified labels for long-term medications: influences on adherence, comprehension and preferences in Malaysia. Int J Clin Pharm. 2014;36(5):904–913. doi: 10.1007/s11096-014-0003-1
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047
   PubMed Web of Science ®Google Scholar
• Vinluan CM, Wittman D, Morisky D. Effect of pharmacist discharge counselling on medication adherence in elderly heart failure patients: a pilot study. J Pharm Health Serv Res. 2015;6(2):103–110. doi: 10.1111/jphs.12093
   Google Scholar
• Katalenich B, Shi L, Liu S, et al. Evaluation of a remote monitoring system for diabetes control. Clin Ther. 2015;37(6):1216–1225. doi: 10.1016/j.clinthera.2015.03.022
   PubMed Web of Science ®Google Scholar
• Kefale B, Tadesse Y, Alebachew M, et al. Management practice, adherence, and its contributing factors among patients with chronic kidney disease at Tikur Anbessa specialized hospital: a hospital-based cross-sectional study. PLOS ONE. 2018;13(7):1–21. doi: 10.1155/2018/2903139
   Web of Science ®Google Scholar
• Obamiro KO, Chalmers L, Lee K, et al. Adherence to oral anticoagulants in atrial fibrillation: an Australian survey. J Cardiovasc Pharmacol Ther. 2018;23(4):337–343. doi: 10.1177/1074248418770201
   PubMed Web of Science ®Google Scholar
• Barcellona D, Mameli A, Cornacchini S, et al. Patients’ adherence to oral anticoagulants therapy: comparison between vitamin K antagonists and direct oral anticoagulants. Int J Cardiol. 2021;333:162–166. doi: 10.1016/j.ijcard.2021.03.003
   PubMed Web of Science ®Google Scholar
• Zyoud SH, Al-Jabi SW, Sweileh WM, et al. Relationship of treatment satisfaction to medication adherence: findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes. 2013;11(1):191. doi: 10.1186/1477-7525-11-191
   PubMedGoogle Scholar
• Aljumah K, Ahmad Hassali A, AlQhatani S. Examining the relationship between adherence and satisfaction with antidepressant treatment. Neuropsychiatr Dis Treat. 2014;10:1433–1438. doi: 10.2147/NDT.S67008
   PubMed Web of Science ®Google Scholar
• Ashur ST, Shamsuddin K, Shah SA, et al. Reliability and known-group validity of the Arabic version of the 8-item morisky medication adherence scale among type 2 diabetes mellitus patients. East Mediterr Health J. 2015;21(10):722–728. doi: 10.26719/2015.21.10.722
   PubMed Web of Science ®Google Scholar
• Alalaqi A, Lawson G, Obaid Y, et al. Adherence to cardiovascular pharmacotherapy by patients in Iraq: a mixed methods assessment using quantitative dried blood spot analysis and the 8-item morisky medication adherence scale. PLOS ONE. 2021;16(5):0251115. doi: 10.1371/journal.pone.0251115
   Web of Science ®Google Scholar
• Monkey S. 2023. [cited 2023 Oct 5]. Available from: https://www.surveymonkey.com/mp/sample-size-calculator/
   Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285(18):2370–2375. doi: 10.1001/jama.285.18.2370
   PubMed Web of Science ®Google Scholar
• Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27(8):949–953. doi: 10.1093/eurheartj/ehi825
   PubMed Web of Science ®Google Scholar
• Castellucci LA, Shaw J, van der Salm K, et al. Self-reported adherence to anticoagulation and its determinants using the morisky medication adherence scale. Thromb Res. 2015;136(4):727–731. doi: 10.1016/j.thromres.2015.07.007
   PubMed Web of Science ®Google Scholar
• Emren SV, Şenöz O, Bilgin M, et al. Drug adherence in patients with nonvalvular atrial fibrillation taking non-vitamin K antagonist oral anticoagulants in Turkey: NOAC-TR. Clin Appl Thromb Hemost. 2018;24(3):525–531. doi: 10.1177/1076029617693940
   PubMed Web of Science ®Google Scholar
• Rome BN, Gagne JJ, Avorn J, et al. Non-warfarin oral anticoagulant copayments and adherence in atrial fibrillation: a population-based cohort study. Am Heart J. 2021;233:109–121. doi: 10.1016/j.ahj.2020.12.010
   PubMed Web of Science ®Google Scholar
• Song T, Xin X, Cui P, et al. Factors associated with anticoagulation adherence in Chinese patients with non-valvular atrial fibrillation. Patient Prefer Adherence. 2021;15:493–500. doi: 10.2147/PPA.S285020
   PubMed Web of Science ®Google Scholar
• Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med. 2011;22(6):597–602. doi: 10.1016/j.ejim.2011.08.029
   PubMed Web of Science ®Google Scholar